Muscarinic M1 and M2 receptors are widely distributed in the brain and contribute to
various physiological and pathological functions. It is well known that enhancement of
cholinergic activity produces convulsions in animals. Pilocarpine, the M1 muscarinic
receptor agonist, is commonly used to induce seizures in rodents. On the other hand
it has been reported that fasted rats and mice pretreated with the M1 and M2 receptor
antagonist atropine, scopolamine or biperiden develop convulsions after food intake
indicating cholinergic hypoactivity as the underlying mechanism. This review will
present pharmacological data for the M1 and M2 receptors in the brain and focus on
the contrasting findings related to their contribution to convulsions.
Primary Language | English |
---|---|
Journal Section | Articles |
Authors | |
Publication Date | December 28, 2018 |
Submission Date | April 7, 2017 |
Published in Issue | Year 2018 Volume: 8 Issue: 4 |